Acinetobacter is an aerobic, non-fermentative gramnegative bacillus, which is widespread in nature (1). Acinetobacter has been recognized as a pathogen which plays a significant role in the colonization and infection in immunocompromised patients. Acinetobacter has been implicated in a variety of nosocomial infections, including bacteremia, urinary tract infection, and ventilator-associated pneumonia, further complicating the illness with its increasing incidence of multi-drug resistance (1, 2). The species other than
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